A rare healthcare issue both parties agree on: A solution to Alzheimer’s that can’t wait

From The Hill

Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer’s and other dementias.

Source Author
Author: Source Author

Written by

Reps. Vern Buchanan (R-Fla.) and Paul Tonko (D-N.Y.), opinion contributors

in

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts